Skip to content

Effects of St John’s Wort on the pharmacokinetics and pharmacodynamics of glyburide related to genetic polymorphisms of cytochrome P450 oxidoreductase

Wort on the pharmacokinetics and pharmacodynamics of glyburide related to genetic polymorphisms of cytochrome P450 oxidoreductase

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RTRCC-12002998
Enrollment
Unknown
Registered
2012-12-22
Start date
2012-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

wide-type:Taking drugs
mutant-type:Taking drugs

Sponsors

Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1) The fasting plasma glucose level less than 7.0 mmol/L; 2) Never using antidiabetic; 3) BMI range from 19 to 24; 4) Healthy Han-Chinese male; 5) Age range from 18to 30 years; 6) Never participating drug trails in the past three months.

Exclusion criteria

Exclusion criteria: 1) Acute cardiocerebrovascular events or myocardial infarction happened in the past 6 mon-ths; 2) Proliferative retinopathy patients by laser; 3) Stress hyperglycemia or secondary hyperglycemia; 4) Unwilling to cooperate; 5) Suffering from mental illness; 6) Allergic to St Johns Wort and glyburide; 7) Combining endocrine diseases or serious primary diseases; 8) Systolic blood pressure is more than or equal to 160 mmHg, and diastolic blood pressure is more than or equal to 100 mmHg or secondary hypertension; 9) Cholesterol is more than or equal to 6.22 mmol/L, or low-density lipoprotein is more than or equal to 4.14 mmol/L; 10) Taking other hypoglycemic drugs.

Design outcomes

Primary

MeasureTime frame
blood concentration;

Contacts

Public ContactFan Lan
fanlan_038038@163.com+86 15074879138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026